X

Titan Pharmaceuticals (TTNP): Q3 2019 Earnings Snapshot

— Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2019 loss of $0.18 per share, vs. $0.21 expected.

— Revenues fell 47% to approx. $0.9 million, vs. $0.7 million expected.

— Product revenues totaled approx. $0.2 million.

— Grant revenues totaled approx. $0.8 million.

— R&D expenses amounted to approx. $1.6 million.

— TTNP shares gained 1% immediately following the announcement.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Related Post